Testing effectiveness (Phase 2)Study completedNCT01063829
What this trial is testing
Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients
Who this might be right for
HCMV Reactivation or HCMV End-Organ Disease
AiCuris Anti-infective Cures AG 133